Disease Markers
Volume 2018 (2018), Article ID 3714684, 1 page
https://doi.org/10.1155/2018/3714684

Corrigendum

Corrigendum to “Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications”

A. Quintanal-Villalonga,1,2 Luis Paz-Ares,1,2,3 Irene Ferrer,1,2 and S. Molina-Pinelo1,2

¹Medical Oncology Department, Hospital Universitario Doce de Octubre, 28041 Madrid, Spain
²Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain
³University of Seville, Seville, Spain

Correspondence should be addressed to S. Molina-Pinelo; pinelo_sonia@hotmail.com

Received 7 May 2018; Accepted 14 June 2018; Published 19 July 2018

Copyright © 2018 A. Quintanal-Villalonga et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the article titled “Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications” [1], there was a missing affiliation for the second author. The corrected authors’ list and affiliations are shown above.

References

A. Quintanal-Villalonga, L. Paz-Ares, I. Ferrer, and S. Molina-Pinelo, “Tyrosine kinase receptor landscape in lung cancer: therapeutical implications,” Disease Markers, vol. 2016, Article ID 9214056, 14 pages, 2016.